Life Science Leader Magazine Supplements

CRO Leadership Awards 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/266911

Contents of this Issue

Navigation

Page 26 of 45

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 25 Eurofins Lancaster Laboratories, Inc. Lancaster, PA www.EurofinsLancasterLabs.com +1 717 656 2300 Michael McDowell, Vice President Business Development and Project Management pha@lancasterlabs.com Key locations: Clogherane, Dungarvan Co. Waterford, Ireland; Lancaster, PA; Portage, MI DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging, Logistics DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical MAIN SERVICE AREAS: Clinical, Preclinical MAIN SERVICE AREAS: Bioanalytical, Clinical, Preclinical "Covance's co mmitment to science and its promise of a healthier world drives us to deliver real solutions to our clients. Our teams of talented professionals and innovative and integrated processes produce high-quality data on time or early, and on budget or below — helping our clients get their new medicines to patients sooner." "It is an honor to receive the CRO Leadership Award for quality, reliability, innovation, and productivity expertise again this year. At Eurofins Lancaster Laboratories, we work extremely hard every day to deliver the most comprehensive, reli- able, and timely GMP testing available for large and small molecule products. We are delighted that the bio/pharmaceutical industry continues to recognize Eurofins Lancaster Laboratories as a leader in these key areas." "We are delighted and honored to be recognized by Life Science Leader. More than anything, this recognition is a direct reflection of both our company ethos, and our talented scientists, who bring deep experience, commitment, and scientific curiosity to every project. I believe this combination of qualities reinforces a company- wide ability to solve technical problems and help our clients consistently manage complexity in drug development." SERVICES & CAPABILITIES: Pharmacology, bioanalysis and biopharmaceutical CMC (small and large molecule), ADME, nonclinical safety assessment, program management, clinical pharmacology and Phase I/IIa trials, early clinical studies, proof-of-concept studies, Phase IIb/III studies, risk-based monitoring, post-registration and Phase IV studies. THERAPEUTIC AREAS: Inflammation, oncology, cardiovascular/metabolic, neuroscience, infectious disease, analgesic, anti-infectives, CNS, dermatology, GI, hematology, hormonal therapy, immunology, ocular, renal disease, respiratory disease. SERVICES & CAPABILITIES: Method development/optimization, validation/ qualification/transfer, product release testing, stability storage & testing, raw materials testing, impurities & residuals testing, characterization, cell banking, cell line characterization, viral clearance, bioassays, professional scientific staffing SM THERAPEUTIC AREAS: As a testing laboratory, we support all therapeutic areas of large and small molecule products. Most importantly, we have expertise in various modalities, including synthetic small molecule pharmaceuticals, as well as cell and gene therapy, synthetic peptides, therapeutic proteins, conjugates, therapeutic enzymes, and vaccines. SERVICES & CAPABILITIES: Offerings include bioanalysis, preclinical DMPK, clinical and bioequivalence studies, API and product development with analytical support–spanning discovery through late-stage clinical trials. Frontage helps a diverse range of clients with data to support NDA, ANDA, and 505.b.2 submissions. THERAPEUTIC AREAS: Frontage supports multiple therapeutic areas across different business areas, with expanded expertise in pain management, oncology, and dermatology for small and large molecules. JOE HERRING chairman and chief executive officer DR. TIMOTHY OOSTDYK president SONG LI, PH.D. chairman and CEO CATEGORIES WON CATEGORIES WON CATEGORIES WON Frontage Exton, PA www.frontagelab.com +1 610 232 0100 Azhar Kalim akalim@frontage lab.com Key locations: Beijing, Changchun, Nanjing, Shanghai, and Zhengzhou, China; Exton, PA, Hackensack, NJ, United States Covance Inc Princeton, NJ www.covance.com +1 609 452 4440 Nigel Brown nigel.brown@covance.com Key locations: Brazil, China, Germany, Russia, Singapore, Switzerland, United Kingdom, United States 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 7 2014 LSL CRO Company Profile Layout That Nice.indd 7 2 / 1 9 / 2 0 1 4 1 : 1 9 : 0 4 P M 2/19/2014 1:19:04 PM

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2014